ISSN:
1573-2568
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary and conclusions We have reviewed various examples of the injurious effects of prostaglandins on the gastrointestinal tract along with evidence that, in certain disease states, nonsteroidal antiinflammatory agents may have a prophylactic or therapeutic effect. The most important areas in which these drugs may be useful are in treatment or prevention of esophagitis, food intolerance symptoms, cholera, radiation-induced diarrhea, and ulcerative colitis. Although these two sets of facts appear to be contradictory, they may actually represent two distinct phenomena. The examples of deleterious effects of prostaglandins on gastrointestinal mucosa are all examples of inflammatory changes. Many changes occur in acute inflammation, including leukocytosis and chemotaxis of neutrophils to the area of inflammation. Release of many substances, including prostaglandins, histamine and bradykinin, occurs into the inflamed site. The prostaglandins involved in inflammation of the gastrointestinal mucosa may be quite different in source, type, and quantity from endogenous prostaglandins which play a role in cytoprotection. In addition, because other substances in addition to prostaglandins are involved in inflammation, and nonsteroidal antiinflammatory agents do not act exclusively by inhibition of prostaglandin synthesis, the therapeutic benefit of antiinflammatory agents in gastrointestinal mucosa may be due to several mechanisms. Therefore, in spite of the strong evidence indicting nonsteroidal antiinflammatory drugs as occasionally harmful to the gastric, duodenal, and intestinal mucosa, we should not lose sight of their important potential therapeutic role in other areas of the gastrointestinal tract.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF01313590
Permalink
